
    
      The investigators conducted a retrospective cohort study of patients who received a first
      heart transplant at the NTUH(Taiwan) between 1987 and 2015 . Clinical data were obtained and
      a retrospective chart review, and were collected up to 10 years .

      Data was collected from medical records and the heart transplant electronic database
      including: demographic parameters such as age and gender; etiology of heart failure; the
      presence of any of the following comorbidities: history of smoking, diabetes, hypertension,
      peripheral vascular disease and previous sternotomy; pre-transplant cholesterol levels; the
      use of any of the following pretransplant hemodynamic support measures:intravenous inotropes,
      intra-aortic balloon pump and ventricular assist device;creatinine levels; listing status
      according to the UNOS classification; waiting time; heart ischemic time;immunosuppression
      drug levels(cyclosporine,prograft or certican) and development of end stage renal disease
      requiring onset of dialysis therapy.

      Creatinine levels and GFRwere collected before transplantation and then the closest level to
      every month after heart transplant.

      The clinical outcomes of interest analyzed in this study included the development of
      post-transplant end stage renal disease and death.
    
  